AEGiS-NIAID: Statement Of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on National Latino AIDS Awareness Day, October 15, 2007 NIAIDImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to NIAID main menu
DonateNow


Statement Of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on National Latino AIDS Awareness Day, October 15, 2007

U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Wednesday, October 10, 2007
CONTACT: NIAID News Office, 301-402-1663, <email:niaidnews@niaid.nih.gov>


October 15, 2007, marks the fifth annual National Latino AIDS Awareness Day. On this day, the National Institute of Allergy and Infectious Diseases (NIAID) pledges to continue working toward reducing the burden of HIV/AIDS in the Latino community in the United States. We commemorate everyone who has been lost to the disease and recognize those committed individuals who promote HIV/AIDS education and awareness in all communities.

Racial and ethnic minorities continue to be disproportionately affected by the HIV/AIDS epidemic. In 2005, the adult and adolescent AIDS case rate was 3.5 times higher among Latinos than among whites. This is the second highest rate of any racial/ethnic group in the United States. By the end of 2005, an estimated 77,125 Latinos with AIDS in the United States had died.

The Centers for Disease Control and Prevention has estimated that one-quarter of people in the United States living with HIV do not know that they are infected with the virus. This fact -- coupled with stigma and discrimination, misconceptions about the disease, inadequate healthcare and language barriers -- underscores the need to encourage Latinos to become educated about HIV/AIDS and to get tested regularly.

One of NIAID's top priorities is to conduct and support HIV/AIDS research that can help improve the health of millions of people in the United States and around the world. Developing new interventions to combat HIV/AIDS requires involvement from all communities, particularly those most affected by the disease. We all have a role. To determine whether an HIV therapy, a vaccine or another prevention strategy works for everyone -- including Latinos -- men and women from all racial and ethnic backgrounds are needed as clinical trial volunteers and as supporters of those who are considering enrollment.

Fostering strong collaborations with all communities remains a critical goal of HIV/AIDS research. NIAID is committed to working in partnership with the Latino community to raise awareness about HIV transmission, to promote education about HIV prevention and treatment, and encourage involvement in the research process to help in our search for new and more effective prevention and treatment interventions. As we move forward, we must continue to strengthen the partnerships between Latinos and all those involved in the fight against HIV/AIDS, such as government agencies, scientists, activists, and philanthropic, religious and community organizations. Let us use National Latino AIDS Awareness Day as a day to recommit ourselves to this effort.

"Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health in Bethesda, Maryland."

MEDIA INQUIRIES CAN BE DIRECTED TO THE NIAID NEWS AND PUBLIC INFORMATION BRANCH AT 301-402-1663, <EMAIL:NIAIDNEWS@NIAID.NIH.GOV>.

NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.

The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <http://www.nih.gov>.
071010
NI071001


Published 2007 - National Institute of Allergy and Infectious Diseases . All material contained in this report is in the public domain and may be used and reprinted without special permission; citation to source, however, is appreciated.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .